×

Growth Reports

Growth Reports
Report Name

Hemophilia Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replacement Therapy, Gene Therapy, Others), Countries and Companies Report

Hemophilia Therapeutics Market is projected to register a 7.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022269  |   No. of Pages: 205

Hemophilia Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Hemophilia A, Hemophilia B, Hemophilia C, Others), By Therapy (Recombination therapy, Plasma therapy, Others), By Distribution Channel (Hospital, Retail, Online), Countries and Companies Report

Hemophilia Drugs Market is projected to register a 6.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022268  |   No. of Pages: 194

Hemophilia B Market - Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Plasma Derived Coagulation Factor Concentrate, Recombinant Coagulation Factor Concentrates, Desmopressin, Others), By Treatment (On-demand, Prophylaxis), By Route of Administration (Oral, Injectable), By End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Countries and Companies Report

Hemophilia B Market - Market is projected to register a 8.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022267  |   No. of Pages: 190

Hemophilia A Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Recombinant therapies, Plasma-derived therapies, Hormonal therapies), By Indication (Mild, Moderate, Severe), Countries and Companies Report

Hemophilia A Therapeutics Market is projected to register a 7.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022266  |   No. of Pages: 205

Hemophilia A Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Desmopressin, Octocogalfa, Nonacogalfa), By Route of Administration (Injectable, Nasal, Oral), By End-User (Hospitals, Clinics, Others), Countries and Companies Report

Hemophilia A Drugs Market is projected to register a 7.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022265  |   No. of Pages: 195

Hemoglobinopathies Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, Others), By Application (Thalassemia, Sickle Cell Anaemia, Others), Countries and Companies Report

Hemoglobinopathies Treatment Market is projected to register a 9.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022264  |   No. of Pages: 198

Hemoglobin Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Chromatography, Immunoassay, Others), By End-User (Hospitals, Research Centers, Laboratories), Countries and Companies Report

Hemoglobin Testing Market is projected to register a 6.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022263  |   No. of Pages: 190

Hemodialysis Equipment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Dialysis Machines, Hemodialysis Water Treatment Systems, Others), By End-User (In-Center Hemodialysis, Home Hemodialysis), Countries and Companies Report

Hemodialysis Equipment Market is projected to register a 5.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022261  |   No. of Pages: 197

Hemodialysis Catheters Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Cuffed Tunneled Catheter, Non-cuffed Tunneled Catheters, Non-tunneled Catheters), By Tip Configuration (Step-tip Catheters, Split-tip Catheters, Symmetric Catheters), By Material (Silicone, Polyurethane), By Application (Hospitals, Home Dialysis, Others), Countries and Companies Report

Hemodialysis Catheters Market is projected to register a 5.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022260  |   No. of Pages: 193